New program aims to keep opioid overdose survivors on track to recovery
NCT ID NCT03895827
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tested a program called RIMO that helps people who recently survived an opioid overdose get into medication-assisted treatment (MAT). The program uses motivational interviewing and support to encourage people to start and stay on MAT. Researchers worked with first responders in Chicago to identify and enroll 251 participants. The goal is to see if this approach leads to faster treatment initiation and longer recovery.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
Recovery Initiation and Management after Overdose (RIMO) - a behavioral program using motivational interviewing and linkage assistance
What this could lead to
If it works, this program could help more people start and stay on medication-assisted treatment after an overdose, reducing the risk of future overdoses.
What could go wrong
This is a behavioral intervention, not a drug, so results depend on participant engagement. The study is completed but relatively small (251 people) and limited to Chicago, so findings may not apply everywhere.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for OPIOID USE DISORDER are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Chestnut Health Systems
Chicago, Illinois, 60610, United States